{
    "Study":{
      "ProtocolSection":{
        "IdentificationModule":{
          "NCTId":"NCT00012298",
          "NCTIdAliasList":{
            "NCTIdAlias":[
              "NCT01646879"
            ]
          },
          "OrgStudyIdInfo":{
            "OrgStudyId":"NCI-2009-00008"
          },
          "SecondaryIdInfoList":{
            "SecondaryIdInfo":[
              {
                "SecondaryId":"NCI-2009-00008",
                "SecondaryIdType":"Registry Identifier",
                "SecondaryIdDomain":"CTRP (Clinical Trial Reporting Program)"
              },{
                "SecondaryId":"CDR0000068503"
              },{
                "SecondaryId":"MC998C",
                "SecondaryIdType":"Other Identifier",
                "SecondaryIdDomain":"Mayo Clinic"
              },{
                "SecondaryId":"312",
                "SecondaryIdType":"Other Identifier",
                "SecondaryIdDomain":"CTEP"
              }
            ]
          },
          "Organization":{
            "OrgFullName":"National Cancer Institute (NCI)",
            "OrgClass":"NIH"
          },
          "BriefTitle":"Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma",
          "OfficialTitle":"Phase I/II Study of Two Sequential Doses of IDEC-Y2B8 in Patients With Relapsed Low-Grade and Follicular Non-Hodgkin's Lymphoma"
        },
        "StatusModule":{
          "StatusVerifiedDate":"July 2018",
          "OverallStatus":"Terminated",
          "WhyStopped":"Trial completed prematurely.",
          "ExpandedAccessInfo":{
            "HasExpandedAccess":"No"
          },
          "StartDateStruct":{
            "StartDate":"April 2001"
          },
          "PrimaryCompletionDateStruct":{
            "PrimaryCompletionDate":"April 2010",
            "PrimaryCompletionDateType":"Actual"
          },
          "CompletionDateStruct":{
            "CompletionDate":"April 2010",
            "CompletionDateType":"Actual"
          },
          "StudyFirstSubmitDate":"March 3, 2001",
          "StudyFirstSubmitQCDate":"January 26, 2003",
          "StudyFirstPostDateStruct":{
            "StudyFirstPostDate":"January 27, 2003",
            "StudyFirstPostDateType":"Estimate"
          },
          "ResultsFirstSubmitDate":"November 4, 2015",
          "ResultsFirstSubmitQCDate":"November 4, 2015",
          "ResultsFirstPostDateStruct":{
            "ResultsFirstPostDate":"December 17, 2015",
            "ResultsFirstPostDateType":"Estimate"
          },
          "LastUpdateSubmitDate":"July 9, 2018",
          "LastUpdatePostDateStruct":{
            "LastUpdatePostDate":"August 9, 2018",
            "LastUpdatePostDateType":"Actual"
          }
        },
        "SponsorCollaboratorsModule":{
          "ResponsibleParty":{
            "ResponsiblePartyType":"Sponsor"
          },
          "LeadSponsor":{
            "LeadSponsorName":"National Cancer Institute (NCI)",
            "LeadSponsorClass":"NIH"
          }
        },
        "OversightModule":{},
        "DescriptionModule":{
          "BriefSummary":"Phase I/II trial to study the effectiveness of combining radiolabeled monoclonal antibody therapy and rituximab with and without filgrastim and interleukin-11 in treating patients who have relapsed or refractory non-Hodgkin's lymphoma. Radiolabeled monoclonal antibodies can locate cancer cells and deliver cancer-killing substances to them without harming normal cells. Biological therapies such as filgrastim and interleukin-11 use different ways to stimulate the immune system and stop cancer cells from growing.",
          "DetailedDescription":"PRIMARY OBJECTIVES:\n\nI. Determine the maximum tolerated dose (MTD) of yttrium Y 90 ibritumomab tiuxetan (IDEC-90Y2B8) administered with rituximab with and without filgrastim (G-CSF) and interleukin-11 (IL-11) in patients with relapsed low-grade or follicular CD20+ non-Hodgkin's lymphoma. (Phase I) II. Determine the toxicity of this regimen in these patients. III. Determine the response rate in patients treated with this regimen. IV. Compare tumor and normal organ dosimetry with positron emission tomography and computerized tomography scans, subsequent tumor response, and normal organ toxicity by utilizing indium In 111 ibritumomab tiuxetan radioimmunoconjugate scans before each IDEC-90Y2B8 dose in these patients. (Phase I) V. Determine the immune response to this regimen, in terms of human anti-mouse and human anti-chimeric antibody formation, in these patients. (Phase I) VI. Determine whether G-CSF and IL-11 can ameliorate the effect of the MTD of IDEC-90Y2B8 on bone marrow function in these patients. (Phase I) VII. Determine progression-free survival at 3 years. (Phase II)\n\nOUTLINE:\n\nPHASE I: Patients receive rituximab IV on days 1 and 8, indium In 111 ibritumomab tiuxetan IV over 10 minutes on day 1 (for radioimaging), and IDEC-90Y2B8 IV over 10 minutes on day 8. Treatment repeats 24-36 weeks later for a total of 2 courses in the absence of disease progression or unacceptable toxicity. Once the maximum tolerated dose (MTD) of IDEC-90Y2B8 is determined, patients also receive filgrastim (G-CSF) subcutaneously (SC) daily beginning when absolute neutrophil count is less than 1,500/mm3 and continuing until blood counts recover. Patients also receive interleukin-11 (IL-11) SC beginning when platelet count is less than 75,000/mm^3 and continuing until blood counts recover. Patients undergo PBSC transplantation only if marrow recovery is inadequate.\n\nCohorts of 3-6 patients receive escalating doses of IDEC-90Y2B8 until the MTD is determined. The MTD is defined as the dose preceding that at which at least 2 of 6 patients experience dose-limiting toxicity. Once the MTD is determined, additional patients are accrued to determine the MTD of this radioimmunotherapy with the addition of the prophylactic cytokines, G-CSF and IL-11.\n\nPHASE II: Patients receive rituximab, indium In 111 ibritumomab tiuxetan, and IDEC-90Y2B8 IV as determined at the MTD in phase I. Treatment repeats 24-36 weeks later for a total of 2 courses in the absence of disease progression or unacceptable toxicity.\n\nAfter completion of study treatment, patients are followed every 3 months for 1 year, every 4 months for 1 year, every 6 months for 1 year, and then annually for 2 years."
        },
        "ConditionsModule":{
          "ConditionList":{
            "Condition":[
              "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue",
              "Nodal Marginal Zone B-cell Lymphoma",
              "Recurrent Grade 1 Follicular Lymphoma",
              "Recurrent Grade 2 Follicular Lymphoma",
              "Recurrent Grade 3 Follicular Lymphoma",
              "Recurrent Marginal Zone Lymphoma",
              "Recurrent Small Lymphocytic Lymphoma",
              "Splenic Marginal Zone Lymphoma",
              "Waldenstr√∂m Macroglobulinemia"
            ]
          }
        },
        "DesignModule":{
          "StudyType":"Interventional",
          "PhaseList":{
            "Phase":[
              "Phase 1",
              "Phase 2"
            ]
          },
          "DesignInfo":{
            "DesignAllocation":"N/A",
            "DesignInterventionModel":"Single Group Assignment",
            "DesignPrimaryPurpose":"Treatment",
            "DesignMaskingInfo":{
              "DesignMasking":"None (Open Label)"
            }
          },
          "EnrollmentInfo":{
            "EnrollmentCount":"81",
            "EnrollmentType":"Actual"
          }
        },
        "ArmsInterventionsModule":{
          "ArmGroupList":{
            "ArmGroup":[
              {
                "ArmGroupLabel":"Treatment (radiolabeled monoclonal antibody therapy)",
                "ArmGroupType":"Experimental",
                "ArmGroupDescription":"Patients receive rituximab IV on days 1 and 8, indium In 111 ibritumomab tiuxetan IV over 10 minutes on day 1, and yttrium Y 90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8. Patients also receive filgrastim (G-CSF) subcutaneously (SC) and interleukin-11 SC until blood counts recover.",
                "ArmGroupInterventionList":{
                  "ArmGroupInterventionName":[
                    "Biological: rituximab",
                    "Biological: yttrium Y 90 ibritumomab tiuxetan",
                    "Biological: indium In 111 ibritumomab tiuxetan",
                    "Biological: oprelvekin",
                    "Biological: filgrastim"
                  ]
                }
              }
            ]
          },
          "InterventionList":{
            "Intervention":[
              {
                "InterventionType":"Biological",
                "InterventionName":"rituximab",
                "InterventionDescription":"Given IV",
                "InterventionArmGroupLabelList":{
                  "InterventionArmGroupLabel":[
                    "Treatment (radiolabeled monoclonal antibody therapy)"
                  ]
                },
                "InterventionOtherNameList":{
                  "InterventionOtherName":[
                    "IDEC-C2B8",
                    "IDEC-C2B8 monoclonal antibody",
                    "Mabthera",
                    "MOAB IDEC-C2B8",
                    "Rituxan"
                  ]
                }
              },{
                "InterventionType":"Biological",
                "InterventionName":"yttrium Y 90 ibritumomab tiuxetan",
                "InterventionDescription":"Given IV",
                "InterventionArmGroupLabelList":{
                  "InterventionArmGroupLabel":[
                    "Treatment (radiolabeled monoclonal antibody therapy)"
                  ]
                },
                "InterventionOtherNameList":{
                  "InterventionOtherName":[
                    "90Y ibritumomab tiuxetan",
                    "IDEC Y2B8",
                    "Y90 Zevalin",
                    "Y90-labeled ibritumomab tiuxetan"
                  ]
                }
              },{
                "InterventionType":"Biological",
                "InterventionName":"indium In 111 ibritumomab tiuxetan",
                "InterventionDescription":"Given IV",
                "InterventionArmGroupLabelList":{
                  "InterventionArmGroupLabel":[
                    "Treatment (radiolabeled monoclonal antibody therapy)"
                  ]
                },
                "InterventionOtherNameList":{
                  "InterventionOtherName":[
                    "IDEC-In2B8"
                  ]
                }
              },{
                "InterventionType":"Biological",
                "InterventionName":"oprelvekin",
                "InterventionDescription":"Given subcutaneously",
                "InterventionArmGroupLabelList":{
                  "InterventionArmGroupLabel":[
                    "Treatment (radiolabeled monoclonal antibody therapy)"
                  ]
                },
                "InterventionOtherNameList":{
                  "InterventionOtherName":[
                    "adipogenesis inhibitory factor",
                    "IL-11",
                    "interleukin 11",
                    "Neumega"
                  ]
                }
              },{
                "InterventionType":"Biological",
                "InterventionName":"filgrastim",
                "InterventionDescription":"Given subcutaneously",
                "InterventionArmGroupLabelList":{
                  "InterventionArmGroupLabel":[
                    "Treatment (radiolabeled monoclonal antibody therapy)"
                  ]
                },
                "InterventionOtherNameList":{
                  "InterventionOtherName":[
                    "G-CSF",
                    "Neupogen"
                  ]
                }
              }
            ]
          }
        },
        "OutcomesModule":{
          "PrimaryOutcomeList":{
            "PrimaryOutcome":[
              {
                "PrimaryOutcomeMeasure":"Maximum Tolerated Dose (MTD) of Yttrium Y-90 Ibritumomab Tiuxetan (Y2B8) With and Without Filgrastim (G-CSF) and Interleukin-11 (IL-11) (Phase I)",
                "PrimaryOutcomeDescription":"This study is a series of 3 single-arm phase-I trials designed to determine the maximum tolerated dose (MTD) of a 2-cycle combination regimen containing Rituxan + Y2B8 radioimmunotherapy with and without the use of G-CSF and IL-11. Trial 1 will determine the Y2B8 MTD in the combined regimen without growth factors. Trial 2 will evaluate the combined regimen with growth factors. Trial 3 starts IL-11 earlier (when platelet count drops below 150000) and reduces the dosing interval to twice weekly.\n\n> Dose-limiting toxicity (DLT) is defined as an adverse event in the second cycle attributed to treatment and meeting the following criteria: Grade 4 ANC or platelet decrease for 14 days, or grade 3 for 28 days, or any other grade 3 Non-Heme event.\n\n> If at any time 2 or more patients (of a maximum of 6) at any dose level experience DLT, then the MTD will be defined as the previous dose level during that trial. The number of patients with a DLT are reported here.",
                "PrimaryOutcomeTimeFrame":"At 8 weeks"
              },{
                "PrimaryOutcomeMeasure":"Toxicity of Single-dose Y2B8 Radioimmunotherapy With and Without the Use of Growth Factors (Phase I)",
                "PrimaryOutcomeDescription":"Evaluated using the Common Toxicity Criteria (CTC) version 2.0. This data is presented as the number of patients reporting grade 3 or higher, grade 4 or higher, or grade 5 adverse events regardless of event attribution.",
                "PrimaryOutcomeTimeFrame":"Assessed up to week 24"
              },{
                "PrimaryOutcomeMeasure":"Proportion of Patients Who Receive 2 Sequential Doses of Y2B8 Immunotherapy and Are Progression-free (Phase II)",
                "PrimaryOutcomeDescription":"Estimated by the number of successes divided by the total number of evaluable patients. Exact binomial confidence intervals for the true success proportion will be calculated.",
                "PrimaryOutcomeTimeFrame":"At 3 years"
              }
            ]
          },
          "SecondaryOutcomeList":{
            "SecondaryOutcome":[
              {
                "SecondaryOutcomeMeasure":"Association Between the Amounts of Tumor Radiation Indicated by the In2B8 Scan and Tumor Response (Phase I)",
                "SecondaryOutcomeDescription":"Assessed using a correlated logistic regression model and generalized estimating equations (GEE). Covariates such as dose level and use of prophylactic cytokines may also be included in this model. A Wilcoxon test will be used to assess the equality of the distributions of the continuous levels of predicted tumor radiation from the In2B8 scans by response.",
                "SecondaryOutcomeTimeFrame":"At week 12"
              },{
                "SecondaryOutcomeMeasure":"Association Between In2B8 Scan and Positron Emission Tomography Scan Results (Phase I)",
                "SecondaryOutcomeDescription":"Explored using a contingency table and sensitivity and specificity will be calculated using 90% exact confidence intervals.",
                "SecondaryOutcomeTimeFrame":"At week 12"
              },{
                "SecondaryOutcomeMeasure":"Appearance of Tumor and Normal Organ Images on the Second In2B8 Scan (Phase I)",
                "SecondaryOutcomeDescription":"Calculated from the serial gamma camera images. Compared using a signed-rank-test. Scatter plots will be used to further explore relationships between these residence times and Bland- Altman methods can be used to assess the agreement between the first and second In2B8 scan residence times.",
                "SecondaryOutcomeTimeFrame":"At week 12"
              },{
                "SecondaryOutcomeMeasure":"Survival (Phase II)",
                "SecondaryOutcomeDescription":"Estimated using the method of Kaplan-Meier.",
                "SecondaryOutcomeTimeFrame":"From registration to death due to any cause, assessed up to 5 years"
              },{
                "SecondaryOutcomeMeasure":"Time to Disease Progression (Phase II)",
                "SecondaryOutcomeDescription":"Estimated using the method of Kaplan-Meier.",
                "SecondaryOutcomeTimeFrame":"From registration to the earliest date documentation of>disease progression, assessed up to 5 years"
              },{
                "SecondaryOutcomeMeasure":"Tumor Response Rate (Phase II)",
                "SecondaryOutcomeDescription":"Calculated by the number of tumor responses divided by the total number of evaluable patients. An exact binomial confidence interval will be calculated.",
                "SecondaryOutcomeTimeFrame":"Assessed up to 5 years"
              }
            ]
          }
        },
        "EligibilityModule":{
          "EligibilityCriteria":"Inclusion Criteria:\n\nHistologically proven relapsed or refractory low-grade or follicular CD+ non-Hodgkin lymphoma, including 1 of the following:\n\nSmall lymphocytic lymphoma\nLymphoplasmacytoid lymphoma\nFollicular center lymphoma (grades I, II, and III)\nExtranodal marginal zone B-cell lymphoma\nNodal marginal zone B-cell lymphoma\nSplenic marginal zone B-cell lymphoma (monocytoid B-cell lymphoma)\nLess than 25% bone marrow involvement of cellular marrow with lymphoma by bilateral bone marrow aspirate and biopsy\nECOG performance status 0-2\nBidimensionally measurable disease with at least 1 lesion >= 2 cm in the greatest diameter\nNo prior myeloablative therapy with autologous or allogeneic bone marrow transplantation or peripheral blood stem cell support\nNo concurrent corticosteroid therapy, except prednisone (or equivalent) for adrenal failure or < 20mg of prednisone daily\nNo prior external beam radiotherapy to >25% of active bone marrow\nMore than 4 weeks since prior surgery other than diagnostic surgery\nNo other concurrent myelosuppressive antineoplastic agents\nNo prior radioimmunotherapy, including yttrium Y 90 ibritumomab tiuxetan or iodine I 131 monoclonal antibody tositumomab or Lym-1\nNo CNS lymphoma\nNo myelodysplastic syndromes or marrow chromosomal changes suggesting myelodysplasia\nNo HIV or AIDS-related lymphoma\nNo pleural effusion or ascites with lymphoma cells\nNo active infection\nNo other serious non-malignant disease that would preclude study participation\nNo other active primary malignancy\nNo known human anti-mouse or human anti-chimeric antibody\nNo prior skin rash (e.g., Stevens-Johnsons syndrome or toxic epidermal necrolysis) from rituximab therapy\nNot pregnant or nursing\nNegative pregnancy test\nFertile patients must use effective contraception\nAbsolute neutrophil count >= 1,500/mm^3\nPlatelet count >= 150,000/mm^3\nTotal lymphocyte count < 5,000/mm^3 for patients with small lymphocytic lymphoma\nBilirubin =< 2 mg/dL\nCreatinine =< 2 mg/dL",
          "HealthyVolunteers":"No",
          "Gender":"All",
          "MinimumAge":"18 Years",
          "StdAgeList":{
            "StdAge":[
              "Adult",
              "Older Adult"
            ]
          }
        },
        "ContactsLocationsModule":{
          "OverallOfficialList":{
            "OverallOfficial":[
              {
                "OverallOfficialName":"Thomas Witzig",
                "OverallOfficialAffiliation":"Mayo Clinic",
                "OverallOfficialRole":"Principal Investigator"
              }
            ]
          },
          "LocationList":{
            "Location":[
              {
                "LocationFacility":"Mayo Clinic",
                "LocationCity":"Rochester",
                "LocationState":"Minnesota",
                "LocationZip":"55905",
                "LocationCountry":"United States"
              }
            ]
          }
        }
      },
      "ResultsSection":{
        "ParticipantFlowModule":{
          "FlowPreAssignmentDetails":"Phase I is a series of three single-arm trials: Trial 1 will determine the Y2B8 MTD without growth factors, Trial 2 will test the regimen with G-CSF and IL-11 added to the treatment, and Trial 3 tests different levels of IL-11 in the regimen.",
          "FlowGroupList":{
            "FlowGroup":[
              {
                "FlowGroupId":"FG000",
                "FlowGroupTitle":"Treatment: Trial 1, Dose Level 1",
                "FlowGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8."
              },{
                "FlowGroupId":"FG001",
                "FlowGroupTitle":"Treatment: Trial 1, Dose Level 2",
                "FlowGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8."
              },{
                "FlowGroupId":"FG002",
                "FlowGroupTitle":"Treatment: Trial 2, Dose Level 3",
                "FlowGroupDescription":"Cycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000."
              },{
                "FlowGroupId":"FG003",
                "FlowGroupTitle":"Treatment: Trial 2, Dose Level 4",
                "FlowGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000."
              },{
                "FlowGroupId":"FG004",
                "FlowGroupTitle":"Treatment: Trial 3, Dose Level 5",
                "FlowGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
              },{
                "FlowGroupId":"FG005",
                "FlowGroupTitle":"Treatment: Trial 3, Dose Level 6",
                "FlowGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
              },{
                "FlowGroupId":"FG006",
                "FlowGroupTitle":"Treatment : Phase II (Dose Level 6)",
                "FlowGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
              }
            ]
          },
          "FlowPeriodList":{
            "FlowPeriod":[
              {
                "FlowPeriodTitle":"Overall Study",
                "FlowMilestoneList":{
                  "FlowMilestone":[
                    {
                      "FlowMilestoneType":"STARTED",
                      "FlowAchievementList":{
                        "FlowAchievement":[
                          {
                            "FlowAchievementGroupId":"FG000",
                            "FlowAchievementNumSubjects":"11"
                          },{
                            "FlowAchievementGroupId":"FG001",
                            "FlowAchievementNumSubjects":"7"
                          },{
                            "FlowAchievementGroupId":"FG002",
                            "FlowAchievementNumSubjects":"9"
                          },{
                            "FlowAchievementGroupId":"FG003",
                            "FlowAchievementNumSubjects":"4"
                          },{
                            "FlowAchievementGroupId":"FG004",
                            "FlowAchievementNumSubjects":"5"
                          },{
                            "FlowAchievementGroupId":"FG005",
                            "FlowAchievementNumSubjects":"6"
                          },{
                            "FlowAchievementGroupId":"FG006",
                            "FlowAchievementNumSubjects":"39"
                          }
                        ]
                      }
                    },{
                      "FlowMilestoneType":"COMPLETED",
                      "FlowAchievementList":{
                        "FlowAchievement":[
                          {
                            "FlowAchievementGroupId":"FG000",
                            "FlowAchievementNumSubjects":"11"
                          },{
                            "FlowAchievementGroupId":"FG001",
                            "FlowAchievementNumSubjects":"7"
                          },{
                            "FlowAchievementGroupId":"FG002",
                            "FlowAchievementNumSubjects":"9"
                          },{
                            "FlowAchievementGroupId":"FG003",
                            "FlowAchievementNumSubjects":"4"
                          },{
                            "FlowAchievementGroupId":"FG004",
                            "FlowAchievementNumSubjects":"5"
                          },{
                            "FlowAchievementGroupId":"FG005",
                            "FlowAchievementNumSubjects":"6"
                          },{
                            "FlowAchievementGroupId":"FG006",
                            "FlowAchievementNumSubjects":"39"
                          }
                        ]
                      }
                    },{
                      "FlowMilestoneType":"NOT COMPLETED",
                      "FlowAchievementList":{
                        "FlowAchievement":[
                          {
                            "FlowAchievementGroupId":"FG000",
                            "FlowAchievementNumSubjects":"0"
                          },{
                            "FlowAchievementGroupId":"FG001",
                            "FlowAchievementNumSubjects":"0"
                          },{
                            "FlowAchievementGroupId":"FG002",
                            "FlowAchievementNumSubjects":"0"
                          },{
                            "FlowAchievementGroupId":"FG003",
                            "FlowAchievementNumSubjects":"0"
                          },{
                            "FlowAchievementGroupId":"FG004",
                            "FlowAchievementNumSubjects":"0"
                          },{
                            "FlowAchievementGroupId":"FG005",
                            "FlowAchievementNumSubjects":"0"
                          },{
                            "FlowAchievementGroupId":"FG006",
                            "FlowAchievementNumSubjects":"0"
                          }
                        ]
                      }
                    }
                  ]
                }
              }
            ]
          }
        },
        "BaselineCharacteristicsModule":{
          "BaselineGroupList":{
            "BaselineGroup":[
              {
                "BaselineGroupId":"BG000",
                "BaselineGroupTitle":"Treatment: Trial 1, Dose Level 1",
                "BaselineGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8."
              },{
                "BaselineGroupId":"BG001",
                "BaselineGroupTitle":"Treatment: Trial 1, Dose Level 2",
                "BaselineGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8"
              },{
                "BaselineGroupId":"BG002",
                "BaselineGroupTitle":"Treatment: Trial 2, Dose Level 3",
                "BaselineGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000."
              },{
                "BaselineGroupId":"BG003",
                "BaselineGroupTitle":"Treatment: Trial 2, Dose Level 4",
                "BaselineGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000."
              },{
                "BaselineGroupId":"BG004",
                "BaselineGroupTitle":"Treatment: Trial 3, Dose Level 5",
                "BaselineGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
              },{
                "BaselineGroupId":"BG005",
                "BaselineGroupTitle":"Treatment: Trial 3, Dose Level 6",
                "BaselineGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
              },{
                "BaselineGroupId":"BG006",
                "BaselineGroupTitle":"Treatment : Phase II (Dose Level 6)",
                "BaselineGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
              },{
                "BaselineGroupId":"BG007",
                "BaselineGroupTitle":"Total",
                "BaselineGroupDescription":"Total of all reporting groups"
              }
            ]
          },
          "BaselineDenomList":{
            "BaselineDenom":[
              {
                "BaselineDenomUnits":"Participants",
                "BaselineDenomCountList":{
                  "BaselineDenomCount":[
                    {
                      "BaselineDenomCountGroupId":"BG000",
                      "BaselineDenomCountValue":"11"
                    },{
                      "BaselineDenomCountGroupId":"BG001",
                      "BaselineDenomCountValue":"7"
                    },{
                      "BaselineDenomCountGroupId":"BG002",
                      "BaselineDenomCountValue":"9"
                    },{
                      "BaselineDenomCountGroupId":"BG003",
                      "BaselineDenomCountValue":"4"
                    },{
                      "BaselineDenomCountGroupId":"BG004",
                      "BaselineDenomCountValue":"5"
                    },{
                      "BaselineDenomCountGroupId":"BG005",
                      "BaselineDenomCountValue":"6"
                    },{
                      "BaselineDenomCountGroupId":"BG006",
                      "BaselineDenomCountValue":"39"
                    },{
                      "BaselineDenomCountGroupId":"BG007",
                      "BaselineDenomCountValue":"81"
                    }
                  ]
                }
              }
            ]
          },
          "BaselineMeasureList":{
            "BaselineMeasure":[
              {
                "BaselineMeasureTitle":"Age, Continuous",
                "BaselineMeasureParamType":"Median",
                "BaselineMeasureDispersionType":"Full Range",
                "BaselineMeasureUnitOfMeasure":"years",
                "BaselineClassList":{
                  "BaselineClass":[
                    {
                      "BaselineCategoryList":{
                        "BaselineCategory":[
                          {
                            "BaselineMeasurementList":{
                              "BaselineMeasurement":[
                                {
                                  "BaselineMeasurementGroupId":"BG000",
                                  "BaselineMeasurementValue":"60",
                                  "BaselineMeasurementLowerLimit":"39",
                                  "BaselineMeasurementUpperLimit":"70"
                                },{
                                  "BaselineMeasurementGroupId":"BG001",
                                  "BaselineMeasurementValue":"56",
                                  "BaselineMeasurementLowerLimit":"31",
                                  "BaselineMeasurementUpperLimit":"65"
                                },{
                                  "BaselineMeasurementGroupId":"BG002",
                                  "BaselineMeasurementValue":"52",
                                  "BaselineMeasurementLowerLimit":"37",
                                  "BaselineMeasurementUpperLimit":"70"
                                },{
                                  "BaselineMeasurementGroupId":"BG003",
                                  "BaselineMeasurementValue":"51",
                                  "BaselineMeasurementLowerLimit":"30",
                                  "BaselineMeasurementUpperLimit":"67"
                                },{
                                  "BaselineMeasurementGroupId":"BG004",
                                  "BaselineMeasurementValue":"46",
                                  "BaselineMeasurementLowerLimit":"42",
                                  "BaselineMeasurementUpperLimit":"60"
                                },{
                                  "BaselineMeasurementGroupId":"BG005",
                                  "BaselineMeasurementValue":"59",
                                  "BaselineMeasurementLowerLimit":"28",
                                  "BaselineMeasurementUpperLimit":"62"
                                },{
                                  "BaselineMeasurementGroupId":"BG006",
                                  "BaselineMeasurementValue":"58",
                                  "BaselineMeasurementLowerLimit":"36",
                                  "BaselineMeasurementUpperLimit":"76"
                                },{
                                  "BaselineMeasurementGroupId":"BG007",
                                  "BaselineMeasurementValue":"58",
                                  "BaselineMeasurementLowerLimit":"28",
                                  "BaselineMeasurementUpperLimit":"76"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "BaselineMeasureTitle":"Sex: Female, Male",
                "BaselineMeasureParamType":"Count of Participants",
                "BaselineMeasureUnitOfMeasure":"Participants",
                "BaselineClassList":{
                  "BaselineClass":[
                    {
                      "BaselineCategoryList":{
                        "BaselineCategory":[
                          {
                            "BaselineCategoryTitle":"Female",
                            "BaselineMeasurementList":{
                              "BaselineMeasurement":[
                                {
                                  "BaselineMeasurementGroupId":"BG000",
                                  "BaselineMeasurementValue":"4"
                                },{
                                  "BaselineMeasurementGroupId":"BG001",
                                  "BaselineMeasurementValue":"4"
                                },{
                                  "BaselineMeasurementGroupId":"BG002",
                                  "BaselineMeasurementValue":"2"
                                },{
                                  "BaselineMeasurementGroupId":"BG003",
                                  "BaselineMeasurementValue":"2"
                                },{
                                  "BaselineMeasurementGroupId":"BG004",
                                  "BaselineMeasurementValue":"3"
                                },{
                                  "BaselineMeasurementGroupId":"BG005",
                                  "BaselineMeasurementValue":"1"
                                },{
                                  "BaselineMeasurementGroupId":"BG006",
                                  "BaselineMeasurementValue":"17"
                                },{
                                  "BaselineMeasurementGroupId":"BG007",
                                  "BaselineMeasurementValue":"33"
                                }
                              ]
                            }
                          },{
                            "BaselineCategoryTitle":"Male",
                            "BaselineMeasurementList":{
                              "BaselineMeasurement":[
                                {
                                  "BaselineMeasurementGroupId":"BG000",
                                  "BaselineMeasurementValue":"7"
                                },{
                                  "BaselineMeasurementGroupId":"BG001",
                                  "BaselineMeasurementValue":"3"
                                },{
                                  "BaselineMeasurementGroupId":"BG002",
                                  "BaselineMeasurementValue":"7"
                                },{
                                  "BaselineMeasurementGroupId":"BG003",
                                  "BaselineMeasurementValue":"2"
                                },{
                                  "BaselineMeasurementGroupId":"BG004",
                                  "BaselineMeasurementValue":"2"
                                },{
                                  "BaselineMeasurementGroupId":"BG005",
                                  "BaselineMeasurementValue":"5"
                                },{
                                  "BaselineMeasurementGroupId":"BG006",
                                  "BaselineMeasurementValue":"22"
                                },{
                                  "BaselineMeasurementGroupId":"BG007",
                                  "BaselineMeasurementValue":"48"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "BaselineMeasureTitle":"Region of Enrollment",
                "BaselineMeasureParamType":"Number",
                "BaselineMeasureUnitOfMeasure":"participants",
                "BaselineClassList":{
                  "BaselineClass":[
                    {
                      "BaselineClassTitle":"Saudi Arabia",
                      "BaselineCategoryList":{
                        "BaselineCategory":[
                          {
                            "BaselineMeasurementList":{
                              "BaselineMeasurement":[
                                {
                                  "BaselineMeasurementGroupId":"BG000",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG001",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG002",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG003",
                                  "BaselineMeasurementValue":"1"
                                },{
                                  "BaselineMeasurementGroupId":"BG004",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG005",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG006",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG007",
                                  "BaselineMeasurementValue":"1"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineClassTitle":"Croatia",
                      "BaselineCategoryList":{
                        "BaselineCategory":[
                          {
                            "BaselineMeasurementList":{
                              "BaselineMeasurement":[
                                {
                                  "BaselineMeasurementGroupId":"BG000",
                                  "BaselineMeasurementValue":"1"
                                },{
                                  "BaselineMeasurementGroupId":"BG001",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG002",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG003",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG004",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG005",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG006",
                                  "BaselineMeasurementValue":"0"
                                },{
                                  "BaselineMeasurementGroupId":"BG007",
                                  "BaselineMeasurementValue":"1"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineClassTitle":"United States",
                      "BaselineCategoryList":{
                        "BaselineCategory":[
                          {
                            "BaselineMeasurementList":{
                              "BaselineMeasurement":[
                                {
                                  "BaselineMeasurementGroupId":"BG000",
                                  "BaselineMeasurementValue":"10"
                                },{
                                  "BaselineMeasurementGroupId":"BG001",
                                  "BaselineMeasurementValue":"7"
                                },{
                                  "BaselineMeasurementGroupId":"BG002",
                                  "BaselineMeasurementValue":"9"
                                },{
                                  "BaselineMeasurementGroupId":"BG003",
                                  "BaselineMeasurementValue":"3"
                                },{
                                  "BaselineMeasurementGroupId":"BG004",
                                  "BaselineMeasurementValue":"5"
                                },{
                                  "BaselineMeasurementGroupId":"BG005",
                                  "BaselineMeasurementValue":"6"
                                },{
                                  "BaselineMeasurementGroupId":"BG006",
                                  "BaselineMeasurementValue":"39"
                                },{
                                  "BaselineMeasurementGroupId":"BG007",
                                  "BaselineMeasurementValue":"79"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              }
            ]
          }
        },
        "OutcomeMeasuresModule":{
          "OutcomeMeasureList":{
            "OutcomeMeasure":[
              {
                "OutcomeMeasureType":"Primary",
                "OutcomeMeasureTitle":"Maximum Tolerated Dose (MTD) of Yttrium Y-90 Ibritumomab Tiuxetan (Y2B8) With and Without Filgrastim (G-CSF) and Interleukin-11 (IL-11) (Phase I)",
                "OutcomeMeasureDescription":"This study is a series of 3 single-arm phase-I trials designed to determine the maximum tolerated dose (MTD) of a 2-cycle combination regimen containing Rituxan + Y2B8 radioimmunotherapy with and without the use of G-CSF and IL-11. Trial 1 will determine the Y2B8 MTD in the combined regimen without growth factors. Trial 2 will evaluate the combined regimen with growth factors. Trial 3 starts IL-11 earlier (when platelet count drops below 150000) and reduces the dosing interval to twice weekly.\n\n> Dose-limiting toxicity (DLT) is defined as an adverse event in the second cycle attributed to treatment and meeting the following criteria: Grade 4 ANC or platelet decrease for 14 days, or grade 3 for 28 days, or any other grade 3 Non-Heme event.\n\n> If at any time 2 or more patients (of a maximum of 6) at any dose level experience DLT, then the MTD will be defined as the previous dose level during that trial. The number of patients with a DLT are reported here.",
                "OutcomeMeasurePopulationDescription":"DLTs were determined in the second cycle of combined treatment. Only Phase I patients that were evaluated after 2 cycles of treatment are included in this evaluation. Two patients at Dose Level 1, 1 patient at Dose Level 2, 4 patients at Dose Level 3, and 1 patient at Dose Level 5 were not evaluated for MTD.",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureParamType":"Number",
                "OutcomeMeasureUnitOfMeasure":"Patients reporting Dose-Limiting Events",
                "OutcomeMeasureTimeFrame":"At 8 weeks",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment: Trial 1, Dose Level 1",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8"
                    },{
                      "OutcomeGroupId":"OG001",
                      "OutcomeGroupTitle":"Treatment: Trial 1, Dose Level 2",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8"
                    },{
                      "OutcomeGroupId":"OG002",
                      "OutcomeGroupTitle":"Treatment: Trial 2, Dose Level 3",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n50 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000."
                    },{
                      "OutcomeGroupId":"OG003",
                      "OutcomeGroupTitle":"Treatment: Trial 2, Dose Level 4",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000."
                    },{
                      "OutcomeGroupId":"OG004",
                      "OutcomeGroupTitle":"Treatment: Trial 3, Dose Level 5",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
                    },{
                      "OutcomeGroupId":"OG005",
                      "OutcomeGroupTitle":"Treatment: Trial 3, Dose Level 6",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"9"
                          },{
                            "OutcomeDenomCountGroupId":"OG001",
                            "OutcomeDenomCountValue":"6"
                          },{
                            "OutcomeDenomCountGroupId":"OG002",
                            "OutcomeDenomCountValue":"5"
                          },{
                            "OutcomeDenomCountGroupId":"OG003",
                            "OutcomeDenomCountValue":"4"
                          },{
                            "OutcomeDenomCountGroupId":"OG004",
                            "OutcomeDenomCountValue":"4"
                          },{
                            "OutcomeDenomCountGroupId":"OG005",
                            "OutcomeDenomCountValue":"6"
                          }
                        ]
                      }
                    }
                  ]
                },
                "OutcomeClassList":{
                  "OutcomeClass":[
                    {
                      "OutcomeCategoryList":{
                        "OutcomeCategory":[
                          {
                            "OutcomeMeasurementList":{
                              "OutcomeMeasurement":[
                                {
                                  "OutcomeMeasurementGroupId":"OG000",
                                  "OutcomeMeasurementValue":"0"
                                },{
                                  "OutcomeMeasurementGroupId":"OG001",
                                  "OutcomeMeasurementValue":"2"
                                },{
                                  "OutcomeMeasurementGroupId":"OG002",
                                  "OutcomeMeasurementValue":"0"
                                },{
                                  "OutcomeMeasurementGroupId":"OG003",
                                  "OutcomeMeasurementValue":"2"
                                },{
                                  "OutcomeMeasurementGroupId":"OG004",
                                  "OutcomeMeasurementValue":"0"
                                },{
                                  "OutcomeMeasurementGroupId":"OG005",
                                  "OutcomeMeasurementValue":"1"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "OutcomeMeasureType":"Primary",
                "OutcomeMeasureTitle":"Toxicity of Single-dose Y2B8 Radioimmunotherapy With and Without the Use of Growth Factors (Phase I)",
                "OutcomeMeasureDescription":"Evaluated using the Common Toxicity Criteria (CTC) version 2.0. This data is presented as the number of patients reporting grade 3 or higher, grade 4 or higher, or grade 5 adverse events regardless of event attribution.",
                "OutcomeMeasurePopulationDescription":"All patients that were evaluated for adverse events after at least one cycle of treatment were used in this analysis.",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureParamType":"Number",
                "OutcomeMeasureUnitOfMeasure":"participants",
                "OutcomeMeasureTimeFrame":"Assessed up to week 24",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment: Trial 1, Dose Level 1",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8"
                    },{
                      "OutcomeGroupId":"OG001",
                      "OutcomeGroupTitle":"Treatment: Trial 1, Dose Level 2",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8"
                    },{
                      "OutcomeGroupId":"OG002",
                      "OutcomeGroupTitle":"Treatment: Trial 2, Dose Level 3",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000."
                    },{
                      "OutcomeGroupId":"OG003",
                      "OutcomeGroupTitle":"Treatment: Trial 2, Dose Level 4",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 12-24 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000."
                    },{
                      "OutcomeGroupId":"OG004",
                      "OutcomeGroupTitle":"Treatment: Trial 3, Dose Level 5",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
                    },{
                      "OutcomeGroupId":"OG005",
                      "OutcomeGroupTitle":"Treatment: Trial 3, Dose Level 6",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"11"
                          },{
                            "OutcomeDenomCountGroupId":"OG001",
                            "OutcomeDenomCountValue":"7"
                          },{
                            "OutcomeDenomCountGroupId":"OG002",
                            "OutcomeDenomCountValue":"9"
                          },{
                            "OutcomeDenomCountGroupId":"OG003",
                            "OutcomeDenomCountValue":"4"
                          },{
                            "OutcomeDenomCountGroupId":"OG004",
                            "OutcomeDenomCountValue":"5"
                          },{
                            "OutcomeDenomCountGroupId":"OG005",
                            "OutcomeDenomCountValue":"6"
                          }
                        ]
                      }
                    }
                  ]
                },
                "OutcomeClassList":{
                  "OutcomeClass":[
                    {
                      "OutcomeClassTitle":"Grade 3+ Adverse Event",
                      "OutcomeCategoryList":{
                        "OutcomeCategory":[
                          {
                            "OutcomeMeasurementList":{
                              "OutcomeMeasurement":[
                                {
                                  "OutcomeMeasurementGroupId":"OG000",
                                  "OutcomeMeasurementValue":"9"
                                },{
                                  "OutcomeMeasurementGroupId":"OG001",
                                  "OutcomeMeasurementValue":"6"
                                },{
                                  "OutcomeMeasurementGroupId":"OG002",
                                  "OutcomeMeasurementValue":"8"
                                },{
                                  "OutcomeMeasurementGroupId":"OG003",
                                  "OutcomeMeasurementValue":"4"
                                },{
                                  "OutcomeMeasurementGroupId":"OG004",
                                  "OutcomeMeasurementValue":"5"
                                },{
                                  "OutcomeMeasurementGroupId":"OG005",
                                  "OutcomeMeasurementValue":"6"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeClassTitle":"Grade 4+ Adverse Event",
                      "OutcomeCategoryList":{
                        "OutcomeCategory":[
                          {
                            "OutcomeMeasurementList":{
                              "OutcomeMeasurement":[
                                {
                                  "OutcomeMeasurementGroupId":"OG000",
                                  "OutcomeMeasurementValue":"2"
                                },{
                                  "OutcomeMeasurementGroupId":"OG001",
                                  "OutcomeMeasurementValue":"5"
                                },{
                                  "OutcomeMeasurementGroupId":"OG002",
                                  "OutcomeMeasurementValue":"2"
                                },{
                                  "OutcomeMeasurementGroupId":"OG003",
                                  "OutcomeMeasurementValue":"2"
                                },{
                                  "OutcomeMeasurementGroupId":"OG004",
                                  "OutcomeMeasurementValue":"1"
                                },{
                                  "OutcomeMeasurementGroupId":"OG005",
                                  "OutcomeMeasurementValue":"1"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeClassTitle":"Grade 5 Adverse Event",
                      "OutcomeCategoryList":{
                        "OutcomeCategory":[
                          {
                            "OutcomeMeasurementList":{
                              "OutcomeMeasurement":[
                                {
                                  "OutcomeMeasurementGroupId":"OG000",
                                  "OutcomeMeasurementValue":"0"
                                },{
                                  "OutcomeMeasurementGroupId":"OG001",
                                  "OutcomeMeasurementValue":"0"
                                },{
                                  "OutcomeMeasurementGroupId":"OG002",
                                  "OutcomeMeasurementValue":"0"
                                },{
                                  "OutcomeMeasurementGroupId":"OG003",
                                  "OutcomeMeasurementValue":"0"
                                },{
                                  "OutcomeMeasurementGroupId":"OG004",
                                  "OutcomeMeasurementValue":"0"
                                },{
                                  "OutcomeMeasurementGroupId":"OG005",
                                  "OutcomeMeasurementValue":"0"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "OutcomeMeasureType":"Primary",
                "OutcomeMeasureTitle":"Proportion of Patients Who Receive 2 Sequential Doses of Y2B8 Immunotherapy and Are Progression-free (Phase II)",
                "OutcomeMeasureDescription":"Estimated by the number of successes divided by the total number of evaluable patients. Exact binomial confidence intervals for the true success proportion will be calculated.",
                "OutcomeMeasurePopulationDescription":"Forty-five patients were registered to Dose Level 6 (39 patients registered to the Phase II portion and 6 patients registered to Dose Level 6 in the Phase I portion). Of the 45 patients, 33 patients received 2 sequential doses of Y2B8 and were evaluable for this endpoint.",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureParamType":"Number",
                "OutcomeMeasureDispersionType":"95% Confidence Interval",
                "OutcomeMeasureUnitOfMeasure":"proportion of participants",
                "OutcomeMeasureTimeFrame":"At 3 years",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment : Dose Level 6",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"33"
                          }
                        ]
                      }
                    }
                  ]
                },
                "OutcomeClassList":{
                  "OutcomeClass":[
                    {
                      "OutcomeCategoryList":{
                        "OutcomeCategory":[
                          {
                            "OutcomeMeasurementList":{
                              "OutcomeMeasurement":[
                                {
                                  "OutcomeMeasurementGroupId":"OG000",
                                  "OutcomeMeasurementValue":".45",
                                  "OutcomeMeasurementLowerLimit":".28",
                                  "OutcomeMeasurementUpperLimit":".64"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "OutcomeMeasureType":"Secondary",
                "OutcomeMeasureTitle":"Association Between the Amounts of Tumor Radiation Indicated by the In2B8 Scan and Tumor Response (Phase I)",
                "OutcomeMeasureDescription":"Assessed using a correlated logistic regression model and generalized estimating equations (GEE). Covariates such as dose level and use of prophylactic cytokines may also be included in this model. A Wilcoxon test will be used to assess the equality of the distributions of the continuous levels of predicted tumor radiation from the In2B8 scans by response.",
                "OutcomeMeasurePopulationDescription":"Not collected. Study team decision not to analyze this endpoint.",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureTimeFrame":"At week 12",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment (Radiolabeled Monoclonal Antibody Therapy)",
                      "OutcomeGroupDescription":"Patients receive rituximab IV on days 1 and 8, indium In 111 ibritumomab tiuxetan IV over 10 minutes on day 1, and yttrium Y 90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8. Patients also receive filgrastim (G-CSF) subcutaneously (SC) and interleukin-11 SC until blood counts recover.\n\nrituximab: Given IV\n\nyttrium Y 90 ibritumomab tiuxetan: Given IV\n\nindium In 111 ibritumomab tiuxetan: Given IV\n\noprelvekin: Given subcutaneously\n\nfilgrastim: Given subcutaneously"
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"0"
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "OutcomeMeasureType":"Secondary",
                "OutcomeMeasureTitle":"Association Between In2B8 Scan and Positron Emission Tomography Scan Results (Phase I)",
                "OutcomeMeasureDescription":"Explored using a contingency table and sensitivity and specificity will be calculated using 90% exact confidence intervals.",
                "OutcomeMeasurePopulationDescription":"Not collected. Study team decision not to analyze this endpoint.",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureTimeFrame":"At week 12",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment (Radiolabeled Monoclonal Antibody Therapy)",
                      "OutcomeGroupDescription":"Patients receive rituximab IV on days 1 and 8, indium In 111 ibritumomab tiuxetan IV over 10 minutes on day 1, and yttrium Y 90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8. Patients also receive filgrastim (G-CSF) subcutaneously (SC) and interleukin-11 SC until blood counts recover.\n\nrituximab: Given IV\n\nyttrium Y 90 ibritumomab tiuxetan: Given IV\n\nindium In 111 ibritumomab tiuxetan: Given IV\n\noprelvekin: Given subcutaneously\n\nfilgrastim: Given subcutaneously"
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"0"
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "OutcomeMeasureType":"Secondary",
                "OutcomeMeasureTitle":"Appearance of Tumor and Normal Organ Images on the Second In2B8 Scan (Phase I)",
                "OutcomeMeasureDescription":"Calculated from the serial gamma camera images. Compared using a signed-rank-test. Scatter plots will be used to further explore relationships between these residence times and Bland- Altman methods can be used to assess the agreement between the first and second In2B8 scan residence times.",
                "OutcomeMeasurePopulationDescription":"Not collected. Study team decision not to analyze this endpoint.",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureTimeFrame":"At week 12",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment (Radiolabeled Monoclonal Antibody Therapy)",
                      "OutcomeGroupDescription":"Patients receive rituximab IV on days 1 and 8, indium In 111 ibritumomab tiuxetan IV over 10 minutes on day 1, and yttrium Y 90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8. Patients also receive filgrastim (G-CSF) subcutaneously (SC) and interleukin-11 SC until blood counts recover.\n\nrituximab: Given IV\n\nyttrium Y 90 ibritumomab tiuxetan: Given IV\n\nindium In 111 ibritumomab tiuxetan: Given IV\n\noprelvekin: Given subcutaneously\n\nfilgrastim: Given subcutaneously"
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"0"
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "OutcomeMeasureType":"Secondary",
                "OutcomeMeasureTitle":"Survival (Phase II)",
                "OutcomeMeasureDescription":"Estimated using the method of Kaplan-Meier.",
                "OutcomeMeasurePopulationDescription":"Phase II portion of the study. One patient out of the 39 was deemed ineligible and was not included in survival analysis.",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureParamType":"Median",
                "OutcomeMeasureDispersionType":"95% Confidence Interval",
                "OutcomeMeasureUnitOfMeasure":"years",
                "OutcomeMeasureTimeFrame":"From registration to death due to any cause, assessed up to 5 years",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment : Dose Level 6",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"38"
                          }
                        ]
                      }
                    }
                  ]
                },
                "OutcomeClassList":{
                  "OutcomeClass":[
                    {
                      "OutcomeCategoryList":{
                        "OutcomeCategory":[
                          {
                            "OutcomeMeasurementList":{
                              "OutcomeMeasurement":[
                                {
                                  "OutcomeMeasurementGroupId":"OG000",
                                  "OutcomeMeasurementValue":"NA",
                                  "OutcomeMeasurementLowerLimit":"8.1",
                                  "OutcomeMeasurementUpperLimit":"NA",
                                  "OutcomeMeasurementComment":"Median and upper 95% confidence interval were not reached."
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "OutcomeMeasureType":"Secondary",
                "OutcomeMeasureTitle":"Time to Disease Progression (Phase II)",
                "OutcomeMeasureDescription":"Estimated using the method of Kaplan-Meier.",
                "OutcomeMeasurePopulationDescription":"All eligible phase II patients. One out of the 39 phase II patients was deemed ineligible.",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureParamType":"Median",
                "OutcomeMeasureDispersionType":"95% Confidence Interval",
                "OutcomeMeasureUnitOfMeasure":"years",
                "OutcomeMeasureTimeFrame":"From registration to the earliest date documentation of>disease progression, assessed up to 5 years",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment : Dose Level 6",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"38"
                          }
                        ]
                      }
                    }
                  ]
                },
                "OutcomeClassList":{
                  "OutcomeClass":[
                    {
                      "OutcomeCategoryList":{
                        "OutcomeCategory":[
                          {
                            "OutcomeMeasurementList":{
                              "OutcomeMeasurement":[
                                {
                                  "OutcomeMeasurementGroupId":"OG000",
                                  "OutcomeMeasurementValue":"2",
                                  "OutcomeMeasurementLowerLimit":"1.6",
                                  "OutcomeMeasurementUpperLimit":"NA",
                                  "OutcomeMeasurementComment":"Upper 95% confidence interval was not reached."
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },{
                "OutcomeMeasureType":"Secondary",
                "OutcomeMeasureTitle":"Tumor Response Rate (Phase II)",
                "OutcomeMeasureDescription":"Calculated by the number of tumor responses divided by the total number of evaluable patients. An exact binomial confidence interval will be calculated.",
                "OutcomeMeasurePopulationDescription":"All eligible phase II patients. One of the 39 phase II patients was deemed ineligible",
                "OutcomeMeasureReportingStatus":"Posted",
                "OutcomeMeasureParamType":"Number",
                "OutcomeMeasureDispersionType":"95% Confidence Interval",
                "OutcomeMeasureUnitOfMeasure":"percentage of patients with response",
                "OutcomeMeasureTimeFrame":"Assessed up to 5 years",
                "OutcomeGroupList":{
                  "OutcomeGroup":[
                    {
                      "OutcomeGroupId":"OG000",
                      "OutcomeGroupTitle":"Treatment : Dose Level 6",
                      "OutcomeGroupDescription":"Patients receive:\n\nCycle 1:\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8\n\nCycle 2 (Cycle 2 delivered 24-36 weeks after Cycle 1):\n\n250 mg/m^2 rituximab IV on days 1 and 8, 2 mg (5.0mCi of In-111) Indium (In-111 ibritumomab tiuxetan) IV over 10 minutes on day 1, 0.4 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8.\n\nPatients also receive:\n\n480 mcg filgrastim (G-CSF) subcutaneously (SC) daily when ANC is less than 1500.\n\n50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000."
                    }
                  ]
                },
                "OutcomeDenomList":{
                  "OutcomeDenom":[
                    {
                      "OutcomeDenomUnits":"Participants",
                      "OutcomeDenomCountList":{
                        "OutcomeDenomCount":[
                          {
                            "OutcomeDenomCountGroupId":"OG000",
                            "OutcomeDenomCountValue":"38"
                          }
                        ]
                      }
                    }
                  ]
                },
                "OutcomeClassList":{
                  "OutcomeClass":[
                    {
                      "OutcomeCategoryList":{
                        "OutcomeCategory":[
                          {
                            "OutcomeMeasurementList":{
                              "OutcomeMeasurement":[
                                {
                                  "OutcomeMeasurementGroupId":"OG000",
                                  "OutcomeMeasurementValue":"89.5",
                                  "OutcomeMeasurementLowerLimit":"75.2",
                                  "OutcomeMeasurementUpperLimit":"97.1"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              }
            ]
          }
        },
        "AdverseEventsModule":{
          "EventsFrequencyThreshold":"0",
          "EventsTimeFrame":"Baseline to 30 days post treatment, up to 3 years",
          "EventsDescription":"Some of the observed Adverse Events were collected without regard to the specific Adverse Event Term, but as a general adverse event within an organ system class. These events are noted with the inclusion of \"Other, specify\" in the term.",
          "EventGroupList":{
            "EventGroup":[
              {
                "EventGroupId":"EG000",
                "EventGroupTitle":"Treatment: Trial 1, Dose Level 1",
                "EventGroupDescription":"0.2 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8",
                "EventGroupSeriousNumAffected":"4",
                "EventGroupSeriousNumAtRisk":"11",
                "EventGroupOtherNumAffected":"11",
                "EventGroupOtherNumAtRisk":"11"
              },{
                "EventGroupId":"EG001",
                "EventGroupTitle":"Treatment: Trial 1, Dose Level 2",
                "EventGroupDescription":"0.3 mCi/kg Yttrium (Y-90 ibritumomab tiuxetan (IDEC-90Y2B8) IV over 10 minutes on day 8",
                "EventGroupSeriousNumAffected":"5",
                "EventGroupSeriousNumAtRisk":"7",
                "EventGroupOtherNumAffected":"7",
                "EventGroupOtherNumAtRisk":"7"
              },{
                "EventGroupId":"EG002",
                "EventGroupTitle":"Treatment: Trial 2, Dose Level 3",
                "EventGroupDescription":"50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000.",
                "EventGroupSeriousNumAffected":"4",
                "EventGroupSeriousNumAtRisk":"9",
                "EventGroupOtherNumAffected":"9",
                "EventGroupOtherNumAtRisk":"9"
              },{
                "EventGroupId":"EG003",
                "EventGroupTitle":"Treatment: Trial 2, Dose Level 4",
                "EventGroupDescription":"50 micrograms/kg Interleukin-11 SC when PLT counts less than 75,000.",
                "EventGroupSeriousNumAffected":"2",
                "EventGroupSeriousNumAtRisk":"4",
                "EventGroupOtherNumAffected":"4",
                "EventGroupOtherNumAtRisk":"4"
              },{
                "EventGroupId":"EG004",
                "EventGroupTitle":"Treatment: Trial 3, Dose Level 5",
                "EventGroupDescription":"50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000.",
                "EventGroupSeriousNumAffected":"1",
                "EventGroupSeriousNumAtRisk":"5",
                "EventGroupOtherNumAffected":"5",
                "EventGroupOtherNumAtRisk":"5"
              },{
                "EventGroupId":"EG005",
                "EventGroupTitle":"Treatment: Trial 3, Dose Level 6",
                "EventGroupDescription":"50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000.",
                "EventGroupSeriousNumAffected":"1",
                "EventGroupSeriousNumAtRisk":"6",
                "EventGroupOtherNumAffected":"6",
                "EventGroupOtherNumAtRisk":"6"
              },{
                "EventGroupId":"EG006",
                "EventGroupTitle":"Treatment : Phase II (Dose Level 6)",
                "EventGroupDescription":"50 micrograms/kg Interleukin-11 SC when PLT counts less than 150,000.",
                "EventGroupSeriousNumAffected":"6",
                "EventGroupSeriousNumAtRisk":"39",
                "EventGroupOtherNumAffected":"39",
                "EventGroupOtherNumAtRisk":"39"
              }
            ]
          },
          "SeriousEventList":{
            "SeriousEvent":[
              {
                "SeriousEventTerm":"Anemia",
                "SeriousEventOrganSystem":"Blood and lymphatic system disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"9",
                      "SeriousEventStatsNumAffected":"2",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Blood and lymphatic system disorders - Other, specify",
                "SeriousEventOrganSystem":"Blood and lymphatic system disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"12",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Supraventricular tachycardia",
                "SeriousEventOrganSystem":"Cardiac disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Abdominal pain",
                "SeriousEventOrganSystem":"Gastrointestinal disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Diarrhea",
                "SeriousEventOrganSystem":"Gastrointestinal disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Fatigue",
                "SeriousEventOrganSystem":"General disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"General disorders and administration site conditions - Other, specify",
                "SeriousEventOrganSystem":"General disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Pain",
                "SeriousEventOrganSystem":"General disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"6",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Infections and infestations - Other, specify",
                "SeriousEventOrganSystem":"Infections and infestations",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"9",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Wound infection",
                "SeriousEventOrganSystem":"Infections and infestations",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Neutrophil count decreased",
                "SeriousEventOrganSystem":"Investigations",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"21",
                      "SeriousEventStatsNumAffected":"4",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"6",
                      "SeriousEventStatsNumAffected":"2",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"18",
                      "SeriousEventStatsNumAffected":"5",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Platelet count decreased",
                "SeriousEventOrganSystem":"Investigations",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"12",
                      "SeriousEventStatsNumAffected":"2",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"6",
                      "SeriousEventStatsNumAffected":"2",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"9",
                      "SeriousEventStatsNumAffected":"2",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"6",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"15",
                      "SeriousEventStatsNumAffected":"3",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"White blood cell decreased",
                "SeriousEventOrganSystem":"Investigations",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"6",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"12",
                      "SeriousEventStatsNumAffected":"3",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Dehydration",
                "SeriousEventOrganSystem":"Metabolism and nutrition disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Confusion",
                "SeriousEventOrganSystem":"Psychiatric disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"6",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Renal and urinary disorders - Other, specify",
                "SeriousEventOrganSystem":"Renal and urinary disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Vaginal hemorrhage",
                "SeriousEventOrganSystem":"Reproductive system and breast disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Dyspnea",
                "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"6",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Erythema multiforme",
                "SeriousEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Urticaria",
                "SeriousEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Hypotension",
                "SeriousEventOrganSystem":"Vascular disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "SeriousEventTerm":"Thromboembolic event",
                "SeriousEventOrganSystem":"Vascular disorders",
                "SeriousEventSourceVocabulary":"MedDRA 12",
                "SeriousEventAssessmentType":"Systematic Assessment",
                "SeriousEventStatsList":{
                  "SeriousEventStats":[
                    {
                      "SeriousEventStatsGroupId":"EG000",
                      "SeriousEventStatsNumEvents":"3",
                      "SeriousEventStatsNumAffected":"1",
                      "SeriousEventStatsNumAtRisk":"11"
                    },{
                      "SeriousEventStatsGroupId":"EG001",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"7"
                    },{
                      "SeriousEventStatsGroupId":"EG002",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"9"
                    },{
                      "SeriousEventStatsGroupId":"EG003",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"4"
                    },{
                      "SeriousEventStatsGroupId":"EG004",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"5"
                    },{
                      "SeriousEventStatsGroupId":"EG005",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"6"
                    },{
                      "SeriousEventStatsGroupId":"EG006",
                      "SeriousEventStatsNumEvents":"0",
                      "SeriousEventStatsNumAffected":"0",
                      "SeriousEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              }
            ]
          },
          "OtherEventList":{
            "OtherEvent":[
              {
                "OtherEventTerm":"Anemia",
                "OtherEventOrganSystem":"Blood and lymphatic system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"93",
                      "OtherEventStatsNumAffected":"10",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"90",
                      "OtherEventStatsNumAffected":"7",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"57",
                      "OtherEventStatsNumAffected":"9",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"51",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"33",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"72",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"330",
                      "OtherEventStatsNumAffected":"34",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Blood and lymphatic system disorders - Other, specify",
                "OtherEventOrganSystem":"Blood and lymphatic system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Febrile neutropenia",
                "OtherEventOrganSystem":"Blood and lymphatic system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Atrial flutter",
                "OtherEventOrganSystem":"Cardiac disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Cardiac disorders - Other, specify",
                "OtherEventOrganSystem":"Cardiac disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"33",
                      "OtherEventStatsNumAffected":"9",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Sinus tachycardia",
                "OtherEventOrganSystem":"Cardiac disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Supraventricular tachycardia",
                "OtherEventOrganSystem":"Cardiac disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Ear pain",
                "OtherEventOrganSystem":"Ear and labyrinth disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Endocrine disorders - Other, specify",
                "OtherEventOrganSystem":"Endocrine disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Blurred vision",
                "OtherEventOrganSystem":"Eye disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Conjunctivitis",
                "OtherEventOrganSystem":"Eye disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Dry eye",
                "OtherEventOrganSystem":"Eye disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Extraocular muscle paresis",
                "OtherEventOrganSystem":"Eye disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Flashing lights",
                "OtherEventOrganSystem":"Eye disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Keratitis",
                "OtherEventOrganSystem":"Eye disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Watering eyes",
                "OtherEventOrganSystem":"Eye disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Abdominal pain",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Bloating",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Constipation",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Diarrhea",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Dry mouth",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Duodenal obstruction",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Dyspepsia",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Esophagitis",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Flatulence",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Gastrointestinal disorders - Other, specify",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Mucositis oral",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Nausea",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"21",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"48",
                      "OtherEventStatsNumAffected":"13",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Vomiting",
                "OtherEventOrganSystem":"Gastrointestinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Chills",
                "OtherEventOrganSystem":"General disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Edema limbs",
                "OtherEventOrganSystem":"General disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Fatigue",
                "OtherEventOrganSystem":"General disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"84",
                      "OtherEventStatsNumAffected":"21",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Fever",
                "OtherEventOrganSystem":"General disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"General disorders and administration site conditions - Other, specify",
                "OtherEventOrganSystem":"General disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Injection site reaction",
                "OtherEventOrganSystem":"General disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Non-cardiac chest pain",
                "OtherEventOrganSystem":"General disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Pain",
                "OtherEventOrganSystem":"General disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Allergic reaction",
                "OtherEventOrganSystem":"Immune system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"21",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Immune system disorders - Other, specify",
                "OtherEventOrganSystem":"Immune system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Bladder infection",
                "OtherEventOrganSystem":"Infections and infestations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Infections and infestations - Other, specify",
                "OtherEventOrganSystem":"Infections and infestations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"36",
                      "OtherEventStatsNumAffected":"11",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Skin infection",
                "OtherEventOrganSystem":"Infections and infestations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Wound infection",
                "OtherEventOrganSystem":"Infections and infestations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Bruising",
                "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Fracture",
                "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Alkaline phosphatase increased",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Aspartate aminotransferase increased",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Blood bilirubin increased",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Cholesterol high",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Creatinine increased",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Lymphocyte count decreased",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Neutrophil count decreased",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"93",
                      "OtherEventStatsNumAffected":"9",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"141",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"147",
                      "OtherEventStatsNumAffected":"9",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"105",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"60",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"102",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"477",
                      "OtherEventStatsNumAffected":"32",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Platelet count decreased",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"129",
                      "OtherEventStatsNumAffected":"10",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"117",
                      "OtherEventStatsNumAffected":"7",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"102",
                      "OtherEventStatsNumAffected":"8",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"84",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"93",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"126",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"711",
                      "OtherEventStatsNumAffected":"39",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Weight gain",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Weight loss",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"White blood cell decreased",
                "OtherEventOrganSystem":"Investigations",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"135",
                      "OtherEventStatsNumAffected":"11",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"192",
                      "OtherEventStatsNumAffected":"7",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"180",
                      "OtherEventStatsNumAffected":"9",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"123",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"72",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"93",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"675",
                      "OtherEventStatsNumAffected":"34",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Anorexia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"21",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Dehydration",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hypercalcemia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hyperglycemia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"33",
                      "OtherEventStatsNumAffected":"8",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"30",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"30",
                      "OtherEventStatsNumAffected":"9",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hyperkalemia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hyperuricemia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hypocalcemia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hypoglycemia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hypokalemia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hypophosphatemia",
                "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Arthralgia",
                "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"33",
                      "OtherEventStatsNumAffected":"10",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Arthritis",
                "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Bone pain",
                "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Myalgia",
                "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"18",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"30",
                      "OtherEventStatsNumAffected":"9",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Treatment related secondary malignancy",
                "OtherEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Dizziness",
                "OtherEventOrganSystem":"Nervous system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Dysgeusia",
                "OtherEventOrganSystem":"Nervous system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Extrapyramidal disorder",
                "OtherEventOrganSystem":"Nervous system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Headache",
                "OtherEventOrganSystem":"Nervous system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"27",
                      "OtherEventStatsNumAffected":"8",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Neuralgia",
                "OtherEventOrganSystem":"Nervous system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Peripheral sensory neuropathy",
                "OtherEventOrganSystem":"Nervous system disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Depression",
                "OtherEventOrganSystem":"Psychiatric disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Insomnia",
                "OtherEventOrganSystem":"Psychiatric disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Urinary frequency",
                "OtherEventOrganSystem":"Renal and urinary disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Urinary incontinence",
                "OtherEventOrganSystem":"Renal and urinary disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Urinary tract pain",
                "OtherEventOrganSystem":"Renal and urinary disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Erectile dysfunction",
                "OtherEventOrganSystem":"Reproductive system and breast disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Gynecomastia",
                "OtherEventOrganSystem":"Reproductive system and breast disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Irregular menstruation",
                "OtherEventOrganSystem":"Reproductive system and breast disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Allergic rhinitis",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Cough",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"4",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Dyspnea",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Epistaxis",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Pleural effusion",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Pleuritic pain",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Pneumonitis",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Respiratory, thoracic and mediastinal disorders - Other, specify",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Voice alteration",
                "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Alopecia",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Dry skin",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Erythema multiforme",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hyperhidrosis",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Pruritus",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"24",
                      "OtherEventStatsNumAffected":"6",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Purpura",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Rash maculo-papular",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"3",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"15",
                      "OtherEventStatsNumAffected":"5",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Skin and subcutaneous tissue disorders - Other, specify",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"6",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"12",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Urticaria",
                "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"9",
                      "OtherEventStatsNumAffected":"2",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Flushing",
                "OtherEventOrganSystem":"Vascular disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hot flashes",
                "OtherEventOrganSystem":"Vascular disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Hypertension",
                "OtherEventOrganSystem":"Vascular disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Phlebitis",
                "OtherEventOrganSystem":"Vascular disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Thromboembolic event",
                "OtherEventOrganSystem":"Vascular disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              },{
                "OtherEventTerm":"Vascular disorders - Other, specify",
                "OtherEventOrganSystem":"Vascular disorders",
                "OtherEventSourceVocabulary":"MedDRA 12",
                "OtherEventAssessmentType":"Systematic Assessment",
                "OtherEventStatsList":{
                  "OtherEventStats":[
                    {
                      "OtherEventStatsGroupId":"EG000",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"11"
                    },{
                      "OtherEventStatsGroupId":"EG001",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"7"
                    },{
                      "OtherEventStatsGroupId":"EG002",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"9"
                    },{
                      "OtherEventStatsGroupId":"EG003",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"4"
                    },{
                      "OtherEventStatsGroupId":"EG004",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"5"
                    },{
                      "OtherEventStatsGroupId":"EG005",
                      "OtherEventStatsNumEvents":"0",
                      "OtherEventStatsNumAffected":"0",
                      "OtherEventStatsNumAtRisk":"6"
                    },{
                      "OtherEventStatsGroupId":"EG006",
                      "OtherEventStatsNumEvents":"3",
                      "OtherEventStatsNumAffected":"1",
                      "OtherEventStatsNumAtRisk":"39"
                    }
                  ]
                }
              }
            ]
          }
        },
        "MoreInfoModule":{
          "CertainAgreement":{
            "AgreementPISponsorEmployee":"No",
            "AgreementRestrictionType":"LTE60",
            "AgreementRestrictiveAgreement":"Yes"
          },
          "PointOfContact":{
            "PointOfContactTitle":"Thomas E. Witzig, M.D.",
            "PointOfContactOrganization":"Mayo Clinic",
            "PointOfContactEMail":"witzig.thomas@mayo.edu"
          }
        }
      },
      "DerivedSection":{
        "MiscInfoModule":{
          "VersionHolder":"April 06, 2022"
        },
        "ConditionBrowseModule":{
          "ConditionMeshList":{
            "ConditionMesh":[
              {
                "ConditionMeshId":"D000008223",
                "ConditionMeshTerm":"Lymphoma"
              },{
                "ConditionMeshId":"D000008224",
                "ConditionMeshTerm":"Lymphoma, Follicular"
              },{
                "ConditionMeshId":"D000008228",
                "ConditionMeshTerm":"Lymphoma, Non-Hodgkin"
              },{
                "ConditionMeshId":"D000016393",
                "ConditionMeshTerm":"Lymphoma, B-Cell"
              },{
                "ConditionMeshId":"D000018442",
                "ConditionMeshTerm":"Lymphoma, B-Cell, Marginal Zone"
              },{
                "ConditionMeshId":"D000015451",
                "ConditionMeshTerm":"Leukemia, Lymphocytic, Chronic, B-Cell"
              },{
                "ConditionMeshId":"D000008258",
                "ConditionMeshTerm":"Waldenstrom Macroglobulinemia"
              }
            ]
          },
          "ConditionAncestorList":{
            "ConditionAncestor":[
              {
                "ConditionAncestorId":"D000009370",
                "ConditionAncestorTerm":"Neoplasms by Histologic Type"
              },{
                "ConditionAncestorId":"D000009369",
                "ConditionAncestorTerm":"Neoplasms"
              },{
                "ConditionAncestorId":"D000008232",
                "ConditionAncestorTerm":"Lymphoproliferative Disorders"
              },{
                "ConditionAncestorId":"D000008206",
                "ConditionAncestorTerm":"Lymphatic Diseases"
              },{
                "ConditionAncestorId":"D000007160",
                "ConditionAncestorTerm":"Immunoproliferative Disorders"
              },{
                "ConditionAncestorId":"D000007154",
                "ConditionAncestorTerm":"Immune System Diseases"
              },{
                "ConditionAncestorId":"D000015448",
                "ConditionAncestorTerm":"Leukemia, B-Cell"
              },{
                "ConditionAncestorId":"D000007945",
                "ConditionAncestorTerm":"Leukemia, Lymphoid"
              },{
                "ConditionAncestorId":"D000007938",
                "ConditionAncestorTerm":"Leukemia"
              },{
                "ConditionAncestorId":"D000054219",
                "ConditionAncestorTerm":"Neoplasms, Plasma Cell"
              },{
                "ConditionAncestorId":"D000020141",
                "ConditionAncestorTerm":"Hemostatic Disorders"
              },{
                "ConditionAncestorId":"D000014652",
                "ConditionAncestorTerm":"Vascular Diseases"
              },{
                "ConditionAncestorId":"D000002318",
                "ConditionAncestorTerm":"Cardiovascular Diseases"
              },{
                "ConditionAncestorId":"D000010265",
                "ConditionAncestorTerm":"Paraproteinemias"
              },{
                "ConditionAncestorId":"D000001796",
                "ConditionAncestorTerm":"Blood Protein Disorders"
              },{
                "ConditionAncestorId":"D000006402",
                "ConditionAncestorTerm":"Hematologic Diseases"
              },{
                "ConditionAncestorId":"D000006474",
                "ConditionAncestorTerm":"Hemorrhagic Disorders"
              }
            ]
          },
          "ConditionBrowseLeafList":{
            "ConditionBrowseLeaf":[
              {
                "ConditionBrowseLeafId":"M10372",
                "ConditionBrowseLeafName":"Lymphoma",
                "ConditionBrowseLeafAsFound":"Lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"M17980",
                "ConditionBrowseLeafName":"Lymphoma, B-Cell",
                "ConditionBrowseLeafAsFound":"B-cell Lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"M19707",
                "ConditionBrowseLeafName":"Lymphoma, B-Cell, Marginal Zone",
                "ConditionBrowseLeafAsFound":"Marginal zone B-cell lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"M17268",
                "ConditionBrowseLeafName":"Leukemia, Lymphocytic, Chronic, B-Cell",
                "ConditionBrowseLeafAsFound":"Small lymphocytic lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"M10403",
                "ConditionBrowseLeafName":"Waldenstrom Macroglobulinemia",
                "ConditionBrowseLeafAsFound":"Waldenstrom Macroglobulinemia",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"M10373",
                "ConditionBrowseLeafName":"Lymphoma, Follicular",
                "ConditionBrowseLeafAsFound":"Follicular lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"M10374",
                "ConditionBrowseLeafName":"Lymphoma, Non-Hodgkin",
                "ConditionBrowseLeafAsFound":"Non-Hodgkin's Lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"M10097",
                "ConditionBrowseLeafName":"Leukemia",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M11467",
                "ConditionBrowseLeafName":"Neoplasms by Histologic Type",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M10377",
                "ConditionBrowseLeafName":"Lymphoproliferative Disorders",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M10355",
                "ConditionBrowseLeafName":"Lymphatic Diseases",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M9358",
                "ConditionBrowseLeafName":"Immunoproliferative Disorders",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M9352",
                "ConditionBrowseLeafName":"Immune System Diseases",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M17267",
                "ConditionBrowseLeafName":"Leukemia, B-Cell",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M10103",
                "ConditionBrowseLeafName":"Leukemia, Lymphoid",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M26741",
                "ConditionBrowseLeafName":"Neoplasms, Plasma Cell",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M21130",
                "ConditionBrowseLeafName":"Hemostatic Disorders",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M4211",
                "ConditionBrowseLeafName":"Blood Coagulation Disorders",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M16552",
                "ConditionBrowseLeafName":"Vascular Diseases",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M12330",
                "ConditionBrowseLeafName":"Paraproteinemias",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M4229",
                "ConditionBrowseLeafName":"Blood Protein Disorders",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M8642",
                "ConditionBrowseLeafName":"Hematologic Diseases",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"M8712",
                "ConditionBrowseLeafName":"Hemorrhagic Disorders",
                "ConditionBrowseLeafRelevance":"low"
              },{
                "ConditionBrowseLeafId":"T3543",
                "ConditionBrowseLeafName":"Lymphosarcoma",
                "ConditionBrowseLeafAsFound":"Lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"T640",
                "ConditionBrowseLeafName":"B-cell Lymphoma",
                "ConditionBrowseLeafAsFound":"B-cell Lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"T3612",
                "ConditionBrowseLeafName":"Marginal Zone Lymphoma",
                "ConditionBrowseLeafAsFound":"Marginal zone lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"T1308",
                "ConditionBrowseLeafName":"Chronic Lymphocytic Leukemia",
                "ConditionBrowseLeafAsFound":"Small lymphocytic lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"T5887",
                "ConditionBrowseLeafName":"Waldenstrom Macroglobulinemia",
                "ConditionBrowseLeafAsFound":"Waldenstrom Macroglobulinemia",
                "ConditionBrowseLeafRelevance":"high"
              },{
                "ConditionBrowseLeafId":"T2361",
                "ConditionBrowseLeafName":"Follicular Lymphoma",
                "ConditionBrowseLeafAsFound":"Follicular lymphoma",
                "ConditionBrowseLeafRelevance":"high"
              }
            ]
          },
          "ConditionBrowseBranchList":{
            "ConditionBrowseBranch":[
              {
                "ConditionBrowseBranchAbbrev":"BC04",
                "ConditionBrowseBranchName":"Neoplasms"
              },{
                "ConditionBrowseBranchAbbrev":"BC15",
                "ConditionBrowseBranchName":"Blood and Lymph Conditions"
              },{
                "ConditionBrowseBranchAbbrev":"BC20",
                "ConditionBrowseBranchName":"Immune System Diseases"
              },{
                "ConditionBrowseBranchAbbrev":"All",
                "ConditionBrowseBranchName":"All Conditions"
              },{
                "ConditionBrowseBranchAbbrev":"BC14",
                "ConditionBrowseBranchName":"Heart and Blood Diseases"
              },{
                "ConditionBrowseBranchAbbrev":"Rare",
                "ConditionBrowseBranchName":"Rare Diseases"
              }
            ]
          }
        },
        "InterventionBrowseModule":{
          "InterventionMeshList":{
            "InterventionMesh":[
              {
                "InterventionMeshId":"D000069283",
                "InterventionMeshTerm":"Rituximab"
              },{
                "InterventionMeshId":"C000105308",
                "InterventionMeshTerm":"Oprelvekin"
              },{
                "InterventionMeshId":"D000000911",
                "InterventionMeshTerm":"Antibodies, Monoclonal"
              }
            ]
          },
          "InterventionAncestorList":{
            "InterventionAncestor":[
              {
                "InterventionAncestorId":"D000074322",
                "InterventionAncestorTerm":"Antineoplastic Agents, Immunological"
              },{
                "InterventionAncestorId":"D000000970",
                "InterventionAncestorTerm":"Antineoplastic Agents"
              },{
                "InterventionAncestorId":"D000007155",
                "InterventionAncestorTerm":"Immunologic Factors"
              },{
                "InterventionAncestorId":"D000045505",
                "InterventionAncestorTerm":"Physiological Effects of Drugs"
              },{
                "InterventionAncestorId":"D000018501",
                "InterventionAncestorTerm":"Antirheumatic Agents"
              }
            ]
          },
          "InterventionBrowseLeafList":{
            "InterventionBrowseLeaf":[
              {
                "InterventionBrowseLeafId":"M3377",
                "InterventionBrowseLeafName":"Antibodies",
                "InterventionBrowseLeafRelevance":"low"
              },{
                "InterventionBrowseLeafId":"M9336",
                "InterventionBrowseLeafName":"Immunoglobulins",
                "InterventionBrowseLeafRelevance":"low"
              },{
                "InterventionBrowseLeafId":"M3382",
                "InterventionBrowseLeafName":"Antibodies, Monoclonal",
                "InterventionBrowseLeafAsFound":"Enzalutamide",
                "InterventionBrowseLeafRelevance":"high"
              },{
                "InterventionBrowseLeafId":"M373",
                "InterventionBrowseLeafName":"Rituximab",
                "InterventionBrowseLeafAsFound":"Caregivers",
                "InterventionBrowseLeafRelevance":"high"
              },{
                "InterventionBrowseLeafId":"M1945",
                "InterventionBrowseLeafName":"Lenograstim",
                "InterventionBrowseLeafRelevance":"low"
              },{
                "InterventionBrowseLeafId":"M258213",
                "InterventionBrowseLeafName":"Oprelvekin",
                "InterventionBrowseLeafAsFound":"Root Canal Therapy",
                "InterventionBrowseLeafRelevance":"high"
              },{
                "InterventionBrowseLeafId":"M1346",
                "InterventionBrowseLeafName":"Antineoplastic Agents, Immunological",
                "InterventionBrowseLeafRelevance":"low"
              },{
                "InterventionBrowseLeafId":"M9353",
                "InterventionBrowseLeafName":"Immunologic Factors",
                "InterventionBrowseLeafRelevance":"low"
              },{
                "InterventionBrowseLeafId":"M19757",
                "InterventionBrowseLeafName":"Antirheumatic Agents",
                "InterventionBrowseLeafRelevance":"low"
              }
            ]
          },
          "InterventionBrowseBranchList":{
            "InterventionBrowseBranch":[
              {
                "InterventionBrowseBranchAbbrev":"All",
                "InterventionBrowseBranchName":"All Drugs and Chemicals"
              },{
                "InterventionBrowseBranchAbbrev":"ANeo",
                "InterventionBrowseBranchName":"Antineoplastic Agents"
              },{
                "InterventionBrowseBranchAbbrev":"ARhu",
                "InterventionBrowseBranchName":"Antirheumatic Agents"
              }
            ]
          }
        }
      }
    }
}
